Rakovina Therapeutics Inc.
RKV.V
TSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.28% | 8.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 25.70% | 7.95% | |||
| Operating Income | -25.70% | -7.95% | |||
| Income Before Tax | -24.18% | -7.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -24.18% | -7.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.18% | -7.45% | |||
| EBIT | -25.70% | -7.95% | |||
| EBITDA | -30.91% | -10.20% | |||
| EPS Basic | 2.35% | -6.25% | |||
| Normalized Basic EPS | 1.89% | -6.00% | |||
| EPS Diluted | 2.35% | -6.25% | |||
| Normalized Diluted EPS | 1.89% | -6.00% | |||
| Average Basic Shares Outstanding | 26.81% | 0.89% | |||
| Average Diluted Shares Outstanding | 26.81% | 0.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||